FULGENT GENETICS, INC. Income Tax Expense
FULGENT GENETICS, INC. (FLGT) reported Income Tax Expense of $29.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-07-30
- FULGENT GENETICS, INC. income tax expense (benefit) for the quarter ending 2026-06-30 was $29.00K.
- FULGENT GENETICS, INC. income tax expense (benefit) for the quarter ending 2026-03-31 was -$704.00K, a 500.00% decline year-over-year.
- FULGENT GENETICS, INC. income tax expense (benefit) for the quarter ending 2025-12-31 was -$5.62M.
- FULGENT GENETICS, INC. income tax expense (benefit) for the quarter ending 2025-09-30 was -$683.00K.
- FULGENT GENETICS, INC. income tax expense (benefit) for fiscal 2025 was -$8.39M.
- FULGENT GENETICS, INC. income tax expense (benefit) for fiscal 2024 was -$8.14M, a 805.03% decline from fiscal 2023.
- FULGENT GENETICS, INC. income tax expense (benefit) for fiscal 2023 was $1.15M, a 97.26% decline from fiscal 2022.
- FULGENT GENETICS, INC. income tax expense (benefit) for fiscal 2022 was $42.10M, a 75.91% decline from fiscal 2021.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $29.00K 10-Q · filed 2026-07-30 | -$675.00K 10-Q · filed 2026-07-30 | -$6.30M derived: sum of 3 quarters · filed 2026-07-30 | -$6.98M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | -$704.00K 10-Q · filed 2026-05-01 | -$6.33M derived: sum of 2 quarters · filed 2026-05-01 | -$7.01M derived: sum of 3 quarters · filed 2026-05-01 | -$9.27M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | -$5.62M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$6.31M derived: sum of 2 quarters · filed 2026-02-27 | -$8.57M derived: sum of 3 quarters · filed 2026-07-30 | -$8.39M 10-K · filed 2026-02-27 |
| 2025-09-30 | -$683.00K 10-Q · filed 2025-11-07 | -$2.95M derived: sum of 2 quarters · filed 2026-07-30 | -$2.77M 10-Q · filed 2025-11-07 | -$4.63M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | -$2.26M 10-Q · filed 2026-07-30 | -$2.09M 10-Q · filed 2026-07-30 | -$3.94M derived: sum of 3 quarters · filed 2026-07-30 | -$7.78M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $176.00K 10-Q · filed 2026-05-01 | -$1.68M derived: sum of 2 quarters · filed 2026-05-01 | -$5.52M derived: sum of 3 quarters · filed 2026-05-01 | -$7.64M derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | -$1.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$5.69M derived: sum of 2 quarters · filed 2026-02-27 | -$7.82M derived: sum of 3 quarters · filed 2026-02-27 | -$8.14M 10-K · filed 2026-02-27 |
| 2024-09-30 | -$3.84M 10-Q · filed 2025-11-07 | -$5.96M derived: sum of 2 quarters · filed 2025-11-07 | -$6.28M 10-Q · filed 2025-11-07 | -$17.15M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | -$2.12M 10-Q · filed 2025-08-01 | -$2.45M 10-Q · filed 2025-08-01 | -$13.31M derived: sum of 3 quarters · filed 2026-02-27 | $7.01M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | -$327.00K 10-Q · filed 2025-05-02 | -$11.19M derived: sum of 2 quarters · filed 2026-02-27 | $9.14M derived: sum of 3 quarters · filed 2026-02-27 | $6.03M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | -$10.86M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $9.46M derived: sum of 2 quarters · filed 2026-02-27 | $6.35M derived: sum of 3 quarters · filed 2026-02-27 | $1.15M 10-K · filed 2026-02-27 |
| 2023-09-30 | $20.33M 10-Q · filed 2024-11-08 | $17.22M derived: sum of 2 quarters · filed 2024-11-08 | $12.02M 10-Q · filed 2024-11-08 | $2.63M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | -$3.11M 10-Q · filed 2024-08-02 | -$8.31M 10-Q · filed 2024-08-02 | -$17.70M derived: sum of 3 quarters · filed 2024-08-02 | -$17.28M derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | -$5.20M 10-Q · filed 2024-05-03 | -$14.59M derived: sum of 2 quarters · filed 2024-05-03 | -$14.17M derived: sum of 3 quarters · filed 2024-05-03 | -$11.52M derived: sum of 4 quarters · filed 2024-05-03 |
| 2022-12-31 | -$9.39M 10-K · filed 2023-02-28 | -$8.97M derived: sum of 2 quarters · filed 2023-11-03 | -$6.32M derived: sum of 3 quarters · filed 2023-11-03 | $42.10M 10-K · filed 2025-02-28 |
| 2022-09-30 | $414.00K 10-Q · filed 2023-11-03 | $3.07M derived: sum of 2 quarters · filed 2023-11-03 | $51.49M 10-Q · filed 2023-11-03 | $98.64M derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | $2.65M 10-Q · filed 2023-08-04 | $51.07M 10-Q · filed 2023-08-04 | $98.22M derived: sum of 3 quarters · filed 2023-08-04 | $135.77M derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | $48.42M 10-Q · filed 2023-05-05 | $95.57M derived: sum of 2 quarters · filed 2023-05-05 | $133.11M derived: sum of 3 quarters · filed 2023-05-05 | $156.70M derived: sum of 4 quarters · filed 2023-05-05 |
| 2021-12-31 | $47.15M 10-K · filed 2023-02-28 | $84.69M derived: sum of 2 quarters · filed 2023-02-28 | $108.28M derived: sum of 3 quarters · filed 2023-02-28 | $174.79M 10-K · filed 2024-02-28 |
| 2021-09-30 | $37.55M 10-K · filed 2023-02-28 | $61.13M derived: sum of 2 quarters · filed 2023-02-28 | $127.65M 10-Q · filed 2022-11-07 | $186.22M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $23.59M 10-K · filed 2023-02-28 | $90.10M 10-Q · filed 2022-08-04 | $148.67M derived: sum of 3 quarters · filed 2023-02-28 | $163.20M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $66.51M 10-K · filed 2023-02-28 | $125.08M derived: sum of 2 quarters · filed 2023-02-28 | $139.61M derived: sum of 3 quarters · filed 2023-02-28 | $139.01M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $58.57M 10-K · filed 2022-02-28 | $73.10M derived: sum of 2 quarters · filed 2022-02-28 | $72.50M derived: sum of 3 quarters · filed 2022-02-28 | $72.53M 10-K · filed 2023-02-28 |
| 2020-09-30 | $14.53M 10-K · filed 2022-02-28 | $13.93M derived: sum of 2 quarters · filed 2022-02-28 | $13.96M 10-Q · filed 2021-11-09 | $13.92M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | -$599.00K 10-K · filed 2022-02-28 | -$565.00K 10-Q · filed 2021-08-10 | -$603.00K derived: sum of 3 quarters · filed 2022-02-28 | -$542.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $34.00K 10-K · filed 2022-02-28 | -$4.00K derived: sum of 2 quarters · filed 2022-02-28 | $57.00K derived: sum of 3 quarters · filed 2022-02-28 | $64.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | -$38.00K 10-K · filed 2021-03-08 | $23.00K derived: sum of 2 quarters · filed 2021-03-08 | $30.00K derived: sum of 3 quarters · filed 2021-03-08 | $43.00K 10-K · filed 2022-02-28 |
| 2019-09-30 | $61.00K 10-K · filed 2021-03-08 | $68.00K derived: sum of 2 quarters · filed 2021-03-08 | $81.00K 10-Q · filed 2020-11-09 | $969.00K derived: sum of 4 quarters · filed 2021-03-08 |
| 2019-06-30 | $7.00K 10-K · filed 2021-03-08 | $20.00K 10-Q · filed 2020-08-05 | $908.00K derived: sum of 3 quarters · filed 2021-03-08 | $590.00K derived: sum of 4 quarters · filed 2021-03-08 |
| 2019-03-31 | $13.00K 10-K · filed 2021-03-08 | $901.00K derived: sum of 2 quarters · filed 2021-03-08 | $583.00K derived: sum of 3 quarters · filed 2021-03-08 | $483.00K derived: sum of 4 quarters · filed 2021-03-08 |
| 2018-12-31 | $888.00K 10-K · filed 2020-03-13 | $570.00K derived: sum of 2 quarters · filed 2020-03-13 | $470.00K derived: sum of 3 quarters · filed 2020-03-13 | $36.00K 10-K · filed 2020-03-13 |
| 2018-09-30 | -$318.00K 10-K · filed 2020-03-13 | -$418.00K derived: sum of 2 quarters · filed 2020-03-13 | -$852.00K 10-Q · filed 2019-11-08 | -$1.45M derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-06-30 | -$100.00K 10-K · filed 2020-03-13 | -$534.00K 10-Q · filed 2019-08-12 | -$1.13M derived: sum of 3 quarters · filed 2020-03-13 | -$1.54M derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-03-31 | -$434.00K 10-K · filed 2020-03-13 | -$1.03M derived: sum of 2 quarters · filed 2020-03-13 | -$1.45M derived: sum of 3 quarters · filed 2020-03-13 | -$1.55M derived: sum of 4 quarters · filed 2020-03-13 |
| 2017-12-31 | -$596.00K 10-K · filed 2019-03-22 | -$1.01M derived: sum of 2 quarters · filed 2019-03-22 | -$1.12M derived: sum of 3 quarters · filed 2019-03-22 | -$1.01M 10-K · filed 2019-03-22 |
| 2017-09-30 | -$415.00K 10-K · filed 2019-03-22 | -$525.00K derived: sum of 2 quarters · filed 2019-03-22 | -$419.00K 10-Q · filed 2018-11-09 | $84.00K derived: sum of 4 quarters · filed 2019-03-22 |
| 2017-06-30 | -$110.00K 10-K · filed 2019-03-22 | -$4.00K 10-Q · filed 2018-08-13 | $499.00K derived: sum of 3 quarters · filed 2019-03-22 | $916.00K derived: sum of 4 quarters · filed 2019-03-22 |
| 2017-03-31 | $106.00K 10-K · filed 2019-03-22 | $609.00K derived: sum of 2 quarters · filed 2019-03-22 | $1.03M derived: sum of 3 quarters · filed 2019-03-22 | $1.03M derived: sum of 4 quarters · filed 2019-03-22 |
| 2016-12-31 | $503.00K 10-K · filed 2018-03-20 | $920.00K derived: sum of 2 quarters · filed 2018-03-20 | $920.00K derived: sum of 3 quarters · filed 2018-03-20 | $920.00K 10-K · filed 2018-03-20 |
| 2016-09-30 | $417.00K 10-K · filed 2018-03-20 | $417.00K derived: sum of 2 quarters · filed 2018-03-20 | $417.00K 10-Q · filed 2017-11-13 | $417.00K derived: sum of 4 quarters · filed 2018-03-20 |
| 2016-06-30 | $0.00 10-Q · filed 2017-08-14 | $0.00 10-Q · filed 2017-08-14 | $0.00 derived: sum of 3 quarters · filed 2017-08-14 | $0.00 derived: sum of 4 quarters · filed 2017-08-14 |
| 2016-03-31 | $0.00 10-Q · filed 2017-05-09 | $0.00 derived: sum of 2 quarters · filed 2017-05-09 | $0.00 derived: sum of 3 quarters · filed 2017-05-09 | |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-17 | $0.00 derived: sum of 2 quarters · filed 2017-03-17 | $0.00 10-K · filed 2017-03-17 | |
| 2015-09-30 | $0.00 10-Q · filed 2016-11-14 | $0.00 10-Q · filed 2016-11-14 | ||
| 2014-12-31 | $0.00 10-K · filed 2017-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |